» Articles » PMID: 36911663

Meteorin-like/Metrnl, a Novel Secreted Protein Implicated in Inflammation, Immunology, and Metabolism: A Comprehensive Review of Preclinical and Clinical Studies

Overview
Journal Front Immunol
Date 2023 Mar 13
PMID 36911663
Authors
Affiliations
Soon will be listed here.
Abstract

Meteorin-like, also known as Metrnl, Meteorin-β, Subfatin, and Cometin, is a novel secreted protein exerting pleiotropic effects on inflammation, immunology, and metabolism. Earlier research on this hormone focused on regulating energy expenditure and glucose homeostasis. Consequently, several studies attempted to characterize the molecule mechanism of Metrnl in glucose metabolism and obesity-related disorders but reported contradictory clinical results. Recent studies gradually noticed its multiple protective functions in inflammatory immune regulations and cardiometabolic diseases, such as inducing macrophage activation, angiogenesis, tissue remodeling, bone formation, and preventing dyslipidemias. A comprehensive understanding of this novel protein is essential to identify its significance as a potential therapeutic drug or a biomarker of certain diseases. In this review, we present the current knowledge on the physiology of Metrnl and its roles in inflammation, immunology, and metabolism, including animal/cell interventional preclinical studies and human clinical studies. We also describe controversies regarding the data of circulation Metrnl in different disease states to determine its clinical application better.

Citing Articles

Metrnl ameliorates myocardial ischemia-reperfusion injury by activating AMPK-mediated M2 macrophage polarization.

Chen D, Feng Y, Wang H, Lu C, Liu D, Gong C Mol Med. 2025; 31(1):98.

PMID: 40082768 PMC: 11907862. DOI: 10.1186/s10020-025-01150-4.


Metrnl/C-KIT Axis Attenuates Early Brain Injury Following Subarachnoid Hemorrhage by Inhibiting Neuronal Ferroptosis.

Zhou Y, Li J, Yuan Y, Zhang H, Luo X, Wang F CNS Neurosci Ther. 2025; 31(2):e70286.

PMID: 39981761 PMC: 11843251. DOI: 10.1111/cns.70286.


Meteorin-like levels of oral fluids in periodontal health and diseases: a comparative cross-sectional study.

Saglam E, Toraman A, Savran L, Saglam M, Koseoglu S Clin Oral Investig. 2025; 29(2):137.

PMID: 39964474 PMC: 11836087. DOI: 10.1007/s00784-025-06222-7.


Skeletal muscle growth to combat diabetes and obesity: the potential role of muscle-secreted factors.

Sammut M, Thorne B, Melling C Obesity (Silver Spring). 2025; 33(3):435-451.

PMID: 39948829 PMC: 11897867. DOI: 10.1002/oby.24223.


Myokines: metabolic regulation in obesity and type 2 diabetes.

Chen Z, Weng Z, Lin J, Meng Z Life Metab. 2025; 3(3):loae006.

PMID: 39872377 PMC: 11749576. DOI: 10.1093/lifemeta/loae006.


References
1.
Tuncer Kara K, Kizil M, Cakmak E, Yildirim T, Kilinc F, Kuloglu T . Comparison of plasma and salivary meteorin-like protein levels in patients with newly diagnosed Type-2 diabetes and treated with metformin. Eur Rev Med Pharmacol Sci. 2022; 26(19):7145-7150. DOI: 10.26355/eurrev_202210_29900. View

2.
Ushach I, Burkhardt A, Martinez C, Hevezi P, Gerber P, Buhren B . METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages. Clin Immunol. 2014; 156(2):119-27. PMC: 4336607. DOI: 10.1016/j.clim.2014.11.006. View

3.
Yao Z, Lin P, Wang C, Wang K, Sun Y . Administration of metrnl delays the onset of diabetes in non-obese diabetic mice. Endocr J. 2020; 68(2):179-188. DOI: 10.1507/endocrj.EJ20-0351. View

4.
Hong C, Wang Z, Zheng S, Hu W, Wang S, Zhao Y . Metrnl regulates cognitive dysfunction and hippocampal BDNF levels in D-galactose-induced aging mice. Acta Pharmacol Sin. 2022; 44(4):741-751. PMC: 10042843. DOI: 10.1038/s41401-022-01009-y. View

5.
Miao Y, Qin H, Zhong Y, Huang K, Rao C . Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue. J Endocrinol. 2021; 249(2):83-93. PMC: 8052515. DOI: 10.1530/JOE-20-0503. View